Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
For premium support please call: 800-290-4726 more ways to reach us
Ionis (IONS) Q1 adjusted loss per share was wider than the year-ago figure. The company maintains its guidance for 2021. Ionis (IONS) Q1 Loss Widens Year Over Year, Sales Miss
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
In stock markets abroad, indexes moved modestly across much of Europe after finishing mixed in Asia. In the crypto market, bitcoin was trading below $95,000 after threatening to hit $100,000 late ...
Conversely, $2,309.60 per Fair Isaac share may appear expensive in comparison, with its much smaller earnings — about $6 in the most recent quarter — relative to share price.
Various networks and news outlets in North America have provided official live video streams of news for most or all of the day, as described below. The ABC Television Network has provided a live streaming service of world news, known as "ABC News Live," for eighteen hours per day, since 2018. This is available via ABC's official platform on ...
Stock market today: Dow soars 461 points while Nasdaq wavers as tech shares slip ... up 0.5% to $146.67 per share. The company reported another solid earnings beat, ... JPMorgan upped its price ...